Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute and chronic bronchitis

C Carbon1

  • 1Service de Médecine Interne, C.H.U. Bichat-Claude Bernard, Paris, France.

Microbial Drug Resistance (Larchmont, N.Y.)
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Antibiotic therapy is crucial for managing acute exacerbations of chronic bronchitis, requiring adherence to specific guidelines and preventive measures. Monitoring bacterial susceptibility patterns is essential for effective treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of correlation between hydrogen peroxide production and nitric oxide production by cultured rabbit articular chondrocytes treated with fluoroquinolone antimicrobial agents.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia.

Respiratory medicine·2005
Same author

Medecine et maladies infectieuses·2005
Same author

Medecine et maladies infectieuses·2005
Same author

[Ecological risk of antibiotic use: consequences for new molecule evaluation].

Medecine et maladies infectieuses·2005
Same author

[Link between resistance and failure in community-acquired respiratory infections].

Medecine et maladies infectieuses·2005
Same journal

Trends, Patterns, and Demographic Dynamics of Drug Resistance in <i>Mycobacterium tuberculosis</i> and Nontuberculous: A Multi-Year Analysis at the National Tuberculosis Reference Laboratory.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Ceftazidime-Avibactam/Colistin Combination Against Carbapenem-Resistant <i>Pseudomonas aeruginosa: In Vitro</i> Synergy Indicating a Possible Therapeutic Approach.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Rapid Screening of <i>Klebsiella pneumoniae</i> Isolates Reveals Multidrug-Resistant and Virulence Traits in a Tertiary Level Hospital in Panama.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Clinical Characteristics and Genomic Analysis of Vancomycin-Resistant <i>Enterococcus faecium</i> in a Tertiary Hospital in Huizhou.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Burden of Carbapenemase-Producing Enterobacterales in Critical Care Settings: Insights from a Tunisian Intensive Care Unit.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same journal

Distribution of Tetracycline and β-Lactam Resistance Genes in the Oropharyngeal and Anorectal Mucosa of Men Who Have Sex with Men: An Exploratory Study.

Microbial drug resistance (Larchmont, N.Y.)·2026
See all related articles

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • Acute exacerbations of chronic bronchitis (AECB) significantly impact patient management.
  • The exact role of infection and the overall benefit of antibiotic therapy in AECB remain subjects of ongoing research.
  • Antibiotic therapy is a cornerstone of AECB management, necessitating adherence to established protocols.

Purpose of the Study:

  • To emphasize the importance of antibiotic therapy in managing AECB.
  • To highlight the need for precise rules and preventive measures in antibiotic use for AECB.
  • To underscore the significance of monitoring bacterial susceptibility patterns for optimizing therapeutic strategies.

Main Methods:

  • Review of current clinical practices and guidelines for AECB management.

Related Experiment Videos

  • Analysis of the impact of infection on AECB.
  • Evaluation of the role and efficacy of antibiotic therapy in AECB.

    • Main Results:

    • Antibiotic therapy is considered essential for managing AECB.
    • Adherence to specific treatment guidelines and implementation of preventive strategies are crucial for reducing exacerbation frequency and severity.
    • Changes in antibiotic susceptibility patterns of key bacterial pathogens require attention for effective control and strategy development.

    Conclusions:

    • Current antibiotic regimens for AECB remain valuable.
    • Further research into infection's role and antibiotic efficacy is warranted.
    • Strategic antibiotic use, coupled with preventive measures, is key to managing AECB.